New Vernon Capital Holdings II’s Pfizer PFE Stock Holding History

New Vernon Capital Holdings II’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,298	Closed	-$239K	–	93
2023 Q4	$239K	Sell	8,298 -817	-9%	-$24.7K	0.13%	67
2023 Q3	$302K	Buy	9,115 +1,389	+18%	+$49.1K	0.26%	42
2023 Q2	$283K	Buy	7,726 +3,415	+79%	+$133K	0.19%	46
2023 Q1	$176K	Hold	4,311	–	–	0.13%	67
2022 Q4	$221K	Buy	4,311 +4,241	+6,059%	+$203K	0.18%	44
2022 Q3	$3K	Buy	+70	New	+$3.4K	﹤0.01%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

New Vernon Capital Holdings II's PFE Position: Q1 2024 in Review

New Vernon Capital Holdings II sold out of Pfizer (PFE) in Q1 2024, closing a stake of 8,298 shares — an estimated $239K sold.

New Vernon Capital Holdings II first reported a position in PFE in Q3 2022 and held it in 6 quarters. The position peaked at $302K in Q3 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

New Vernon Capital Holdings II reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
New Vernon Capital Holdings II sold 8,298 Pfizer shares in Q1 2024, an estimated $239K.
New Vernon Capital Holdings II first reported a position in Pfizer in Q3 2022 and held it in 6 quarters.
New Vernon Capital Holdings II's Pfizer position peaked at $302K in Q3 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2024, filed 15 May 2024.